Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -4.57 is 75% above its 5-year average of -18.52, near the high end of its 5-year range (-39.68–-3.93).
14.54% below its 12-month average of -3.99.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.18.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 30 comparable quarters.
EARNINGS PER SHARE (EPS)
-4.57
EARNINGS PER SHARE (EPS) AVG TTM
-3.99
EARNINGS PER SHARE (EPS) AVG 3Y
-6.52
EARNINGS PER SHARE (EPS) AVG 5Y
-18.52
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-14.54%
CURRENT VS 3Y AVG
+29.94%
CURRENT VS 5Y AVG
+75.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Tectonic Therapeutic, Inc.
Market Cap
$436.54M
Earnings Per Share (EPS)
-4.57
TTM Avg
-3.99
3Y Avg
-6.52
5Y Avg
-18.52
Market Cap
$437.38M
Earnings Per Share (EPS)
0.55
TTM Avg
-3.62
3Y Avg
-10.86
5Y Avg
-15.74
Market Cap
$441.39M
Earnings Per Share (EPS)
-2.45
TTM Avg
-1.70
3Y Avg
-1.35
5Y Avg
-1.20
Market Cap
$428.93M
Earnings Per Share (EPS)
-0.75
TTM Avg
-2.34
3Y Avg
-2.48
5Y Avg
-2.46
Market Cap
$443.39M
Earnings Per Share (EPS)
-0.57
TTM Avg
-0.80
3Y Avg
-1.19
5Y Avg
-1.52
Market Cap
$428.72M
Earnings Per Share (EPS)
-1.98
TTM Avg
-3.65
3Y Avg
-4.15
5Y Avg
-2.79
Market Cap
$446.12M
Earnings Per Share (EPS)
-0.72
TTM Avg
-0.65
3Y Avg
-0.60
5Y Avg
-0.64
Market Cap
$426.41M
Earnings Per Share (EPS)
-1.33
TTM Avg
-17.45
3Y Avg
-17.77
5Y Avg
-15.77
Market Cap
$448.87M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.30
3Y Avg
-0.53
5Y Avg
-0.29
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. (TECX) | $436.54M | -4.57 | -3.99 | -6.52 | -18.52 |
| Assembly Biosciences, Inc. (ASMB)vs › | $437.38M | 0.55 | -3.62 | -10.86 | -15.74 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $441.39M | -2.45 | -1.70 | -1.35 | -1.20 |
| Editas Medicine, Inc. (EDIT)vs › | $428.93M | -0.75 | -2.34 | -2.48 | -2.46 |
| NeuroPace, Inc. (NPCE)vs › | $443.39M | -0.57 | -0.80 | -1.19 | -1.52 |
| NeoGenomics, Inc. (NEO)vs › | $428.72M | -1.98 | -3.65 | -4.15 | -2.79 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $446.12M | -0.72 | -0.65 | -0.60 | -0.64 |
| Tilray Brands, Inc. (TLRY)vs › | $426.41M | -1.33 | -17.45 | -17.77 | -15.77 |
| Ovid Therapeutics Inc. (OVID)vs › | $448.87M | -0.48 | -0.30 | -0.53 | -0.29 |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $424.52M | -2.18 | -0.83 | -0.77 | -0.64 |
Trailing EPS (TTM)
$-4.57
Forward EPS (Est.)
$-5.09
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.05 |
| 2024-12-31 | -3.93 |
| 2023-12-31 | -11.59 |
| 2021-12-31 | -33.36 |
| 2020-12-31 | -39.68 |
| 2019-12-31 | -31.92 |
| 2018-12-31 | -23.41 |
| 2017-12-31 | -9.35 |
| 2016-12-31 | -2.34 |
